Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMCOpen access

From Design to Application: Advanced Cellulose Scaffolds for Engineered Tissue Regeneration

Tong Y., Cai Y., Wu Y., Zhuo W., Liao J.

Narrative Review on Chronic Wound, published in Polymers (Basel) (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Polymers (Basel) (2026)
Reported sample size
—
Source database
Europe PMC
PMID
41829313
PMCID
PMC12987057
DOI
10.3390/polym18050614

Abstract (original English)

The regeneration of complex tissues demands advanced scaffolds that offer biomimetic support and tissue-specific bioactive guidance. However, the materials in clinic face big challenges with immune rejection, limited donors, and unsatisfactory inductive activity. Fortunately, cellulose-based scaffolds have risen as a leading sustainable platform, considering their natural abundance, inherent biocompatibility, and highly tunable properties. This review comprehensively presented their evolution from rational design to potential clinical application. The primary cellulose sources and key detailed engineering strategies, including chemical modification, composite formulation, and bioactive functionalization, were arranged logically. The modification of cellulose can tune the physical, chemical, and biological behavior of scaffolds, along with advanced three-dimensional printing fabrication techniques. These material advances have enabled targeted functional outcomes in preclinical models, demonstrating promise for specific applications such as wound healing and bone repair. However, their broad clinical translation is contingent upon resolving persistent challenges, including controlled biodegradation and immune compatibility, which we critically assess alongside emerging frontiers such as smart responsive systems. By bridging material innovation with clinical needs, this review ma

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research